Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

NCT06929806 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1900

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure
Iron Deficiencies

Interventions

DRUG: Ferric Derisomaltose

Sponsor

Pharmacosmos A/S